HC Wainwright Issues Optimistic Outlook for ESPR Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities research analysts at HC Wainwright raised their Q2 2025 earnings per share estimates for shares of Esperion Therapeutics in a research note issued to investors on Tuesday, June 17th. HC Wainwright analyst J. Pantginis now expects that the biopharmaceutical company will post earnings per share of […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities research analysts at HC Wainwright raised their Q2 2025 earnings per share estimates for shares of Esperion Therapeutics in a research note issued to investors on Tuesday, June 17th. HC Wainwright analyst J. Pantginis now expects that the biopharmaceutical company will post earnings per share of […]
